Insider Trading Activity West Pharmaceutical Services Inc. (NYSE:WST) – CFO Sold 42,869 shares of Stock

ME Staff
-
0

Insider Trading Activity For West Pharmaceutical Services Inc. (NYSE:WST)

William J Federici , CFO of West Pharmaceutical Services Inc. (NYSE:WST) reportedly Sold 42,869 shares of the company’s stock at an average price of 96.09 for a total transaction amount of $4,119,282.21 SEC Form

Insider Trading History For West Pharmaceutical Services Inc. (NYSE:WST)

  • On 5/8/2013 L Robert Johnson, Director, sold 6,400 with an average share price of $64.49 per share and the total transaction amounting to $412,736.00.
  • On 5/17/2013 L Robert Johnson, Director, sold 4,000 with an average share price of $67.80 per share and the total transaction amounting to $271,200.00.
  • On 5/20/2013 John R Gailey, VP, sold 9,282 with an average share price of $68.54 per share and the total transaction amounting to $636,188.28.
  • On 5/24/2013 L Robert Johnson, Director, sold 1,700 with an average share price of $67.47 per share and the total transaction amounting to $114,699.00.
  • On 5/28/2013 Donald E Morel Jr, CEO, sold 10,000 with an average share price of $67.87 per share and the total transaction amounting to $678,700.00.
  • On 5/31/2013 Michael A Anderson, VP, sold 4,000 with an average share price of $68.94 per share and the total transaction amounting to $275,760.00.
  • On 8/8/2013 Michael A Anderson, VP, sold 4,300 with an average share price of $78.00 per share and the total transaction amounting to $335,400.00.

    • Analyst Ratings History For West Pharmaceutical Services Inc. (NYSE:WST)

    • On 12/23/2016 Janney Montgomery Scott Reiterated Rating Buy
    • On 9/15/2017 Jefferies Financial Group Upgraded rating Hold ➝ Buy with a price target of $96.00 ➝ $115.00
    • On 10/3/2017 Stephens Initiated Coverage of rating Equal ➝ Equal Weight with a price target of $99.00
    • On 10/27/2017 Wells Fargo & Co Boost Price Target of rating Outperform with a price target of $105.00 ➝ $112.00
    • On 1/24/2018 Goldman Sachs Group Initiated Coverage of rating Neutral ➝ Neutral with a price target of $110.00
    • On 4/25/2018 Bank of America Downgraded rating Neutral ➝ Underperform with a price target of $85.00

    Dividend Information For West Pharmaceutical Services Inc. (NYSE:WST)
    West Pharmaceutical Services Inc. (NYSE:WST) pays an annual dividend of $0.56 with a yield of 0.58% and an average dividend growth of 8.90% (3 Year Average).

    Dividend History For West Pharmaceutical Services Inc. (NYSE:WST)

  • On 12/27/2012 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.19 1.4% with an ex dividend date of 1/18/2013 which will be payable on 2/6/2013.
  • On 3/15/2013 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.19 1.21% with an ex dividend date of 4/15/2013 which will be payable on 5/1/2013.
  • On 5/10/2013 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.19 1.16% with an ex dividend date of 7/22/2013 which will be payable on 8/7/2013.
  • On 8/1/2013 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.20 with an ex dividend date of which will be payable on 11/6/2013.
  • On 12/19/2013 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.10 0.81% with an ex dividend date of 1/17/2014 which will be payable on 2/5/2014.
  • On 2/20/2014 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.10 0.83% with an ex dividend date of 4/21/2014 which will be payable on 5/7/2014.
  • On 5/8/2014 West Pharmaceutical Services Inc. announced a quarterly dividend of $0.10 0.94% with an ex dividend date of 7/21/2014 which will be payable on 8/6/2014.

    • Recent Trading Activity for West Pharmaceutical Services Inc. (NYSE:WST)
    Shares of West Pharmaceutical Services Inc. closed the previous trading session at 96.91 up +0.16 0.17% with 54672 shares trading hands.